Institute of Molecular Biotechnology

What Institute of Molecular Biotechnology does

The Institute of Molecular Biotechnology (IMBA) is a Vienna-based non-profit biomedical research institute operating under the Österreichische Akademie der Wissenschaften (Austrian Academy of Sciences, ÖAW), Austria's national academy and largest non-university research institution. Founded in 2003 and headquartered in Vienna, Austria, IMBA conducts advanced molecular biology research with particular prominence in stem cell biology, organoid technology, and molecular genetics. The institute gained European recognition for its pioneering work on brain organoids — miniature lab-grown models of the human brain used to study neurodevelopmental conditions and test treatments.

IMBA operates as a government-affiliated non-profit entity with no public revenue disclosure. Research funding derives primarily from public sources including the Austrian Science Fund (FWF) and European Research Council (ERC) grants. The institute employs 101-250 staff and operates within the broader ÖAW network, which encompasses multiple research institutes across Austria, more than 6,000 academic members, and a publishing arm (ÖAW Press) that distributes scholarly works across humanities, social sciences, and natural sciences. ÖAW Press operates an e-commerce storefront with individual publication pricing ranging from €8 to €208, alongside select Open Access options, and maintains distribution partnerships with JSTOR, CrossRef, and ORCID for digital discoverability.

IMBA serves the European academic and biomedical research community, with no direct paying customers in the commercial sense. Its stakeholder base comprises the Austrian government, EU funding bodies, collaborating universities, and the broader scientific community. The institute participates in international scientific collaborations, academic conferences, and the ÖAW's knowledge transfer programs including spin-off support. Marketing and outreach occur through institutional channels including academic events, science communication multimedia (podcasts, YouTube), social media presence, and the parent organization's publishing infrastructure.

Name

Institute of Molecular Biotechnology

Legal name

Institute of Molecular Biotechnology

Website

https://oeaw.ac.at

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

IMBA is a Vienna-based non-profit molecular biotechnology research institute under the Austrian Academy of Sciences, specializing in stem cell biology, organoid technology, and molecular genetics, primarily funded by public grants including FWF and ERC.

Ownership category

akta.pro rank

Headquarters

HQ city

Vienna

HQ country

Austria

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Others

Revenue model

1. Academic Publishing and Book Sales: The Austrian Academy of Sciences Press (Verlag der Österreichischen Akademie der Wissenschaften) generates revenue through the sale of academic books, journals, and publications across disciplines including classical studies, archaeology, history, linguistics, musicology, and natural sciences. Publications are sold via an e-commerce storefront with pricing ranging from approximately €8 to €208 per item.

Pricing tiers

Distribution channels3 records

Marketing channels6 records

Core offering

IMBA is a non-profit molecular biology and biomedical research institute conducting advanced research in stem cell biology, organoid technology, molecular genetics, and 3D cell culture models, with particular prominence in brain organoid research. Its outputs include peer-reviewed scientific publications, trained researchers, and collaborative research with universities and research institutions across Europe.

Differentiator

Problem solved

Functional benefit

Products and services

• Molecular biology and biomedical research services Fundamental and applied research in molecular biology, stem cell biology, organoid technology, molecular genetics, and 3D cell culture models, delivered to academic collaborators, universities, and research institutions.
• Brain organoid research program Research program producing lab-grown human brain organoid models used by collaborators and academic partners to study neurodevelopmental conditions and test potential treatments.

Quantifiable outcome

• Vienna Yearbook of Population Research achieved Q1 ranking in Scimago Journal-Ranking for the first time in 13 years

Segments1 record

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core.

• JSTORcoreTechnology or IntegrationThe ÖAW Press partners with JSTOR for the digital distribution and academic indexing of its publications, enabling broad discoverability and access for academic institutions worldwide.
• ORCIDcoreTechnology or IntegrationORCID integration is supported and recommended for all authors publishing with the ÖAW Press, enabling unique researcher identification and attribution across publications.
• CrossRefcoreTechnology or IntegrationCrossRef DOI services are used for all ÖAW Press publications, ensuring reliable citation linking and metadata standards.
• Association of European University Presses (AEUP)coreGTM or Marketing PartnerThe ÖAW Press is a member of AEUP, a network of European university presses that promotes scholarly publishing and shares best practices across institutions.
• Arbeitsgemeinschaft der UniversitätsverlagecoreStrategic or Co-development PartnerThe ÖAW Press participates in the Working Group of University Publishers (AG Universitätsverlage), coordinating with other German-speaking academic publishers on shared standards and practices.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• European Molecular Biology Laboratory (EMBL): Intergovernmental research organization with sites across Europe conducting molecular biology and life science research; directly comparable as a publicly funded, multi-site European molecular biology research institute at similar scale and mission.
• Max Planck Institute for Molecular Genetics: German publicly funded research institute focused on molecular genetics, genomics, and developmental biology; closely comparable mission, funding model, and scientific scope to IMBA within the same DACH-region academic ecosystem.
• Francis Crick Institute: Large UK biomedical research institute conducting discovery research in molecular biology, stem cells, and genetics; directly comparable as a non-university, publicly funded biomedical research institute with similar headcount range and translational scope.
• Wellcome Sanger Institute: UK-based genomic and molecular biology research institute; comparable in its focus on molecular genetics, cell biology, and large-scale research infrastructure funded primarily through philanthropic and public grants.
• Whitehead Institute for Biomedical Research: MIT-affiliated non-profit biomedical research institute with similar headcount and focus on molecular biology, stem cells, and genetics; comparable as a small-to-mid-size, mission-driven research institute with strong publishing output.
• Broad Institute of MIT and Harvard: US non-profit biomedical and genomic research organization; comparable in its mission-driven molecular biology and genomics research, though at substantially larger scale and with deeper industry partnership models.
• CeMM Research Center for Molecular Medicine: Vienna-based molecular medicine research institute also operating under the Austrian Academy of Sciences; the closest geographic and institutional peer, conducting molecular-level biomedical research with similar funding structures and ÖAW affiliation.

Broad incumbents

• Institut Pasteur: Historic French non-profit research foundation with broader scope spanning infectious disease, immunology, and molecular biology; comparable as a publicly chartered European research institution, though operating at larger scale and broader thematic range.
• Karolinska Institutet: Sweden's leading medical university with substantial molecular biology and stem cell research programs; comparable as a publicly funded European institution conducting advanced biomedical research, though operating as a university rather than a standalone research institute.

Regional players

• Helmholtz Centre for Infection Research: German publicly funded life sciences research institute within the Helmholtz Association; comparable in its DACH-region public funding model and molecular/cellular biology research portfolio, though more focused on infectious disease.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/oeaw
• YouTubeyoutube.com/channel/UCY3rUdfN-VCjvfUWojWkayQ
• Facebookfacebook.com/oeaw.at
• LinkedInlinkedin.com/company/austrian-academy-of-sciences
• Instagraminstagram.com/oeaw.at

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of Molecular Biotechnology